ArticleJournal for immunotherapy of cancer2020

Targeting ANXA1 abrogates Treg-mediated immune suppression in triple-negative breast cancer.

Fang Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.